Detalhe da pesquisa
1.
IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2.
Proteins
; 90(9): 1732-1743, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35443068
2.
The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases.
BMC Cancer
; 19(1): 812, 2019 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31419957
3.
An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancer.
J Nanobiotechnology
; 16(1): 101, 2018 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30526620
4.
High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2.
Arch Biochem Biophys
; 501(2): 195-200, 2010 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20541521
5.
The Continuing Evolution of Insulin-like Growth Factor Signaling.
F1000Res
; 92020.
Artigo
Inglês
| MEDLINE | ID: mdl-32226608
6.
An assessment of racial differences in epidemiological, clinical and psychosocial factors among head and neck cancer patients at the time of surgery.
World J Otorhinolaryngol Head Neck Surg
; 6(1): 41-48, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32426702
7.
Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.
Transl Oncol
; 12(1): 49-61, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30267961
8.
Acquired Resistance to Drugs Targeting Tyrosine Kinases.
Adv Cancer Res
; 138: 71-98, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29551130
9.
NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma.
Oncotarget
; 9(39): 25503-25516, 2018 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29876004
10.
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma.
Cancer Lett
; 248(2): 269-79, 2007 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-16996205
11.
The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Oncotarget
; 8(14): 22991-23007, 2017 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28160562
12.
Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susceptible to glomerulosclerosis.
Endocrinology
; 147(7): 3547-54, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16556765
13.
Paradoxical effects of the phage display-derived peptide antagonist IGF-F1-1 on insulin-like growth factor-1 receptor signaling.
Biochem Pharmacol
; 72(1): 53-61, 2006 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-16684509
14.
IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.
Invest Ophthalmol Vis Sci
; 45(8): 2838-47, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15277511
15.
What's new in the IGF-binding proteins?
Growth Horm IGF Res
; 14(5): 329-36, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15336228
16.
Role of oxidative stress and the microenvironment in breast cancer development and progression.
Adv Cancer Res
; 119: 107-25, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23870510
17.
Acquired resistance to drugs targeting receptor tyrosine kinases.
Biochem Pharmacol
; 83(8): 1041-8, 2012 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22227013
18.
Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion.
PLoS One
; 7(9): e45197, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23028842
19.
Defining the pathway to insulin-like growth factor system targeting in cancer.
Biochem Pharmacol
; 80(8): 1115-24, 2010 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20599789
20.
Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.
J Immunother
; 33(2): 126-35, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20145550